IQVIA™ Pharma Deals: PharmaDeals Review: Table of Contents

<< Previous Issue

Mar 2024 (Vol: 2024, Issue: 3)

Next Issue >>

Download pdf of entire issue

Section: Mergers & Acquisitions
Gilead to Acquire CymaBay Therapeutics and its Liver Disease Drug for US$4.3 B Published: 2 Mar-2024
By: Lucy Haggerty
Abstract Fulltext:
AstraZeneca Buys Fusion Pharmaceuticals for US$2 B Published: 22 Mar-2024
By: Lucy Haggerty
Abstract Fulltext:
Section: Opinion & Analysis
IQVIA Pharma Deals Review of 2023 Published: 28 Mar-2024
By: Lucy Haggerty, Ayush Saxena & Taskin Ahmed
Abstract Fulltext:
Section: Research & Development
Merck KGaA Pays C4 Therapeutics US$16 M Upfront for Protein Degraders Published: 8 Mar-2024
By: Lucy Haggerty
Abstract Fulltext:
Gilead Collaborates with Merus For Novel Antibody-Based Trispecific T-Cell Engagers Published: 22 Mar-2024
By: Lalit Mishra
Abstract Fulltext:
Boehringer Ingelheim Collaborates with Sosei Heptares for Antipsychotic Drugs Published: 27 Mar-2024
By: Amit Kaushik
Abstract Fulltext:

Login

Username:

Password:

Keep me logged in